资讯

The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc.
梗阻性黄疸实验室检查主要包括血常规、尿常规、便常规、凝血功能、肝肾功能、肿瘤标志物等。影像学检查对其诊断和寻找病因具有重要意义,包括超声、CT、MRI和内窥镜逆行胰胆管造影(ERCP)等影像学检查可以帮助确定梗阻的位置和原因。
In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...
Topline results from a second phase 3 trial of AD109-an investigational oral therapy combining aroxybutynin and ...
The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various socioeconomic and clinical factors.
Obstructive sleep apnea syndrome (OSAS) is a risk factor for hypertensive target organ damage and subsequent cardiovascular disease. Recent guidelines for the management of hypertension have ...
3. Partinen, M, Jamieson, A, Guilleminault, C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988;94:1200-1204 ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase ...
In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death from any cause (hazard ratio, 2.24; 95 percent confidence interval, 1.30 to 3.86; P=0.004).
Obstructive sleep apnea is up to 45% more likely to occur on warmer nights and its global burden may double if temperatures rise 2°C by 2100. #medindia #climatechange #obstructivesleepapnea’ ...